Target intelligence / Profile preview

Simian immunodeficiency virus Pol polyprotein (SIV Pol)

Target
SIV Pol
Molecular classification
Enzyme, Reverse transcriptase, Integrase, Aspartic protease, Ribonuclease
01

Overview

The Simian immunodeficiency virus (SIV) Pol polyprotein is a critical multifunctional precursor protein essential for the replication and maturation of SIV (UniProt: P03366). It is enzymatically cleaved by the viral protease into three primary functional enzymes: protease (PR), reverse transcriptase (RT), and integrase (IN) (PubMed: 24882234). Reverse transcriptase converts the viral RNA genome into double-stranded DNA, while integrase facilitates the insertion of this DNA into the host cell's genome (NCBI: ViralZone). The protease component is responsible for processing the Gag and Gag-Pol polyproteins into mature, functional proteins, a step vital for the production of infectious virions. Because of its central role in the viral life cycle, SIV Pol is a primary target for antiretroviral therapy, with many drugs developed for HIV-1 showing cross-reactivity (PubMed: 15640501). Research into SIV Pol is also crucial for understanding viral evolution and developing animal models for human HIV/AIDS treatments. Therapeutic strategies often involve combination therapy to prevent the emergence of resistant viral strains.

Other names
Pol polyproteinSIV PolymeraseP160 PolGag-Pol polyprotein
02

Mechanism of action

Inhibition of viral enzymes (reverse transcriptase, integrase, or protease) to prevent the synthesis of viral DNA, its integration into the host genome, or the maturation of new viral particles.

03

Biological functions

Viral replicationReverse transcriptionDNA integrationProtein processingViral maturation
04

Disease associations

Simian immunodeficiency virus infectionAcquired immunodeficiency syndrome (AIDS)
05

Safety considerations

Development of drug resistance mutationsPotential for cross-resistanceOff-target effects on host mitochondrial DNA polymeraseMetabolic disturbances
06

Interacting drugs

Tenofovir

6 more in the full profile.

07

Biomarkers

SIV RNA viral loadCD4+ T-cell countSIV p27 antigen

Beyond the preview

Go deeper on Simian immunodeficiency virus Pol polyprotein (SIV Pol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simian immunodeficiency virus Pol polyprotein (SIV Pol).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call